Page last updated: 2024-08-21

pyrazines and edaravone

pyrazines has been researched along with edaravone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dolcet, X; Encinas, M; Eritja, N; Llobet, D; Llombart-Cussac, A; Marti, RM; Matias-Guiu, X; Schoenenberger, JA; Sorolla, A; Yeramian, A	1
Scott, A	1
Gao, G; Sun, C; Sun, Z; Xu, Q; Zhao, M	1

Trials

1 trial(s) available for pyrazines and edaravone

Article	Year
Clinical observation in edaravone treatment for acute cerebral infarction. Nigerian journal of clinical practice, 2019, Volume: 22, Issue:10 Topics: Activities of Daily Living; Aged; Cerebral Infarction; Edaravone; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Neuroprotective Agents; Pyrazines; Treatment Outcome; Vasodilator Agents	2019

Other Studies

2 other study(ies) available for pyrazines and edaravone

Article	Year
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells. Anti-cancer drugs, 2008, Volume: 19, Issue:2 Topics: Antioxidants; Antipyrine; Apoptosis; Ascorbic Acid; Blotting, Western; Boronic Acids; Bortezomib; Butylated Hydroxyanisole; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Coumarins; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Edaravone; Endometrial Neoplasms; Ergothioneine; Female; Humans; Leupeptins; Oligopeptides; Proteasome Inhibitors; Pyrazines; Ubiquitin; Vitamin E; Vitamins	2008
Drug therapy: On the treatment trail for ALS. Nature, 2017, 10-18, Volume: 550, Issue:7676 Topics: Amyotrophic Lateral Sclerosis; Antipyrine; Benzamides; C9orf72 Protein; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Edaravone; Genetic Therapy; Humans; Imidazoles; Mesenchymal Stem Cells; Motor Neurons; Neuroglia; Off-Label Use; Oligoribonucleotides, Antisense; Piperidines; Precision Medicine; Pyrazines; Pyridines; Riluzole; RNAi Therapeutics; Stem Cell Transplantation; Superoxide Dismutase; Thiazoles; United States; United States Food and Drug Administration	2017

Article

Year

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.

Anti-cancer drugs, 2008, Volume: 19, Issue:2

Topics: Antioxidants; Antipyrine; Apoptosis; Ascorbic Acid; Blotting, Western; Boronic Acids; Bortezomib; Butylated Hydroxyanisole; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Coumarins; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Edaravone; Endometrial Neoplasms; Ergothioneine; Female; Humans; Leupeptins; Oligopeptides; Proteasome Inhibitors; Pyrazines; Ubiquitin; Vitamin E; Vitamins

2008

Drug therapy: On the treatment trail for ALS.

Nature, 2017, 10-18, Volume: 550, Issue:7676

Topics: Amyotrophic Lateral Sclerosis; Antipyrine; Benzamides; C9orf72 Protein; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Edaravone; Genetic Therapy; Humans; Imidazoles; Mesenchymal Stem Cells; Motor Neurons; Neuroglia; Off-Label Use; Oligoribonucleotides, Antisense; Piperidines; Precision Medicine; Pyrazines; Pyridines; Riluzole; RNAi Therapeutics; Stem Cell Transplantation; Superoxide Dismutase; Thiazoles; United States; United States Food and Drug Administration

2017